Notice of Hon''ble NCLT Convened Shareholders Meeting in the matter of Scheme of Amalgamation, Scheduled to be held on Tuesday, October 27, 2026 At 12:30 p.m.

BEFORE THE NATIONAL COMPANY LAW TRIBUNAL, IMUMBAI BENCH FORM NO. CAA-3 [Pursuant to Section 230(5) and Rule 8] CA(CAA)/136/MB-IV/2026 In the matter of the Companies Act, 2013; In the matter of Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 and Rules framed thereunder as in force from time to time; In the matter of Scheme of Amalgamation ofPRIVI FENE SCIENCES PRIVATE LIMITED, the Transferor Company 1 and PRIVI BIOTECHNOLOGIES PRIVATE LIMITED, the Transferor Company 2 with PRIVI SPECIALITY CHEMICALS LIMITED, the Transferee Company. Privi Speciality Chemicals Limited (AAACH5113Q) ......Applicant Company Date: 06/10/2026 BSE Limited, Floor 25, PJ Towers, Dalal Street, Mumbai 400001 Email ID: corp.comm@bseindia.com Notice is hereby given in pursuance of sub-section (5) of section 230 of the Companies Act, 2013, that as directed by the Hon'ble Mumbai Bench of National Company Law Tribunal, Mumbai ("Tribunal") at 4th, 5th & 6th Floor, MTNL Exchange Building, Next to G.D. Somani School, Cuffe Parade, Mumbai- 400005 by an order dated 7 September, 2026 has dispensed the requirement of holding the meetings of (a) the members, secured and unsecured creditors of Privi Fine Sciences Private Limited, the Transferor Company 1; (b) the members and unsecured creditors of Privi Biotechnologies Private Limited, the Transferor Company 2; (c) the secured and unsecured creditors of Privi Speciality Chemicals Limited, the Transferee Company. Further, a meeting of the members of Privi Speciality Chemicals Limited, the Transferee Company shall be held on 27th October, 2026 (through OAVM) to consider the Scheme of Amalgamation ofPrivi Fine Sciences Private Limited, the Transferor Company 1 and Privi Biotechnologies Private Limited, the Transferor Company 2 with Privi Speciality Chemicals Limited, the Transferee Company. ^, PRIVI SPECIALITY CHEMICALS LIMITED " ..!sl 1809001:2015 ISO 14001:2015 Knowledge Centre & Regd. Office : Privi House, A-71, TTC, Thane Belapur Road, Near Kopar Khairane Railway Station, '•- 18045001:2018 BUREAU VERITAS Navi Mumbai - 400 710. India | Tel,: +91 22 68713200 / 33043500 / 33043600 / 27783040 / 27783041 / 27783045 Certification Fax: +91 2227783049/68713232 ] Email: enquiry@privi.co.in | Web: www.privi.com | CIN:L15140MH1985PLC286828 ,,...».»........._.^ herewith. You are hereby informed that representations, if any, in connection with the proposed Scheme of Amalgamation may be made to the Tribunal within thirty days from the date of receipt of this notice. Copy of the representation may simultaneously be sent to the respective Company at their registered office address. In case no representation is received within the stated period of thirty days, it shall be presumed that you have no representation to make on the proposed scheme of amalgamation. For Privi Speciality Chemicals Limited, <§K • c % .5; •tp s REGD. •=1 0- OFFICE 5?> Ashwini Saumil Shah t-- « Company Secretary & Compliance officer End: Copy of order dt. 7th September, 2026 Copy of the Notice calling the Meeting of Equity Shareholders Copy of the Scheme of Amalgamation PRIVI SPECIALITY CHEMICALS LIMITED 1809001:2015 18014001:2015 18045001:2018 Knowledge Centre & Regd. Office : Privi House, A-71, TTC, Thane Belapur Road, Near .Kopar Khairane Railway Station, BUREAU VERITAS Navi Mumbai - 400 710. India | Tel.: +91 22 68713200 / 33043500 / 33043600 / 27783040 / 27783041 / 27783045 Certification Fax: +91 2227783049/68713232 | Email: enquiry@privi.co.in | Web: www.privi.com | GIN: L15140MH1985PLC286828 IN THE NATIONAL COMPANY LAW TRIBUNAL, MUMBAI COURT-IV CA(CAA)-136/MB/2026 In the matter of Sections 230 to 232 of the Companies Act, 2013 In the matter of Scheme of Amalgamation Privi Fine Sciences Private Limited (Transferor Company-1/Applicant-1) Privi Biotechnologies Private Limited (Transferor Company-2/Applicant-2) with Privi Speciality Chemicals Limited (Transferee Company/Applicant-3) Privi Fine Sciences Private Limited ….Applicant Company-1/ [CIN: U24110MH2021PTC358857] Transferor Company-1 Privi Biotechnologies Private Limited ….Applicant Company-2/ [CIN: U74220MH1985PTC037534] Transferor Company-2 Privi Speciality Chemicals Limited ….Applicant Company-3/ [CIN: L15140MH1985PLC286828] Transferee Company Pronounced: 07.09.2026 CORAM: SHRI ANIL RAJ CHELLAN SHRI K.R. SAJI KUMAR HON’BLE MEMBER (TECHNICAL) HON’BLE MEMBER (JUDICIAL) Appearance : Hybrid National Company Law Tribunal For the Applicants : Mr. Ashish O. LalpurMiuam baa/i wBe nMchr. Kamal LahoAptpylic,a tPionC NoS.: CCR/NCLT/2026/136/01264 Date of Application: 2026-09-08 No. of Pages: 15 Valid with Facing Sheet Only.: IN THE NATIONAL COMPANY LAW TRIBUNAL, MUMBAI COURT-IV CA(CAA)/136/MB/2026 O R D E R 1. This is an Application filed under Sections 230 to 232 of the Companies Act, 2013, seeking necessary directions of this Tribunal for notices and convening meetings/dispensation of meetings of the shareholders and creditors of the Applicant Companies with respect to the Scheme of Amalgamation of Privi Fine Sciences Private Limited (Transferor Company-1) and Privi Biotechnologies Private Limited (Transferor Company-2) with Privi Speciality Chemicals Limited (Transferee Company). 2. The Applicant Companies stated that the Board of Directors of the Applicant Companies, in their respective meetings held on 19.12.2025, have approved the Scheme. All the relevant resolutions are part of the Application. The Appointed Date fixed for the Scheme is 01.10.2025. 3. The Applicant Companies further stated that Applicant Company 1 and 2 are not listed on any Stock Exchange. The Applicant Companies are not governed by any sectoral regulators. Further, the Applicant Company 1 and 2 are not required to issue notice upon the Securities and Exchange Board of India, Competition Commission of India and Reserve Bank of India. 4. The Applicant Companies further stated that the shares of the Applicant Company 3 are listed on National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) and are governed by the sectoral regulators. Pursuant to which, the Applicant Company 3 has obtained a No Objection Letter from NSE bearing reference no. NSE/LIST/52681 dated 05.05.2026 and a No Objection Letter from BSE bearing reference no. DCS/AMAL/RD/R37/53/2026-27 dated 06.05.2026. Company has furnished an undertaking which is in compliance with the No Objection Letter. Further stated that the Applicant Company 3 is not required to issue notice to the Securities and Exchange Board of India, the Competition National Company Law Tribunal Commission of India, and the Reserve Bank of India. Copy Moufm bleai tBteenrchs from BSE Application No.: CCR/NCLT/2026/136/01264 and NSE are part of the Application. Date of Application: 2026-09-08 No. of Pages: 15 Valid with Facing Sheet Only.: 5. Nature of Business: It is submitted by the Applicant Companies that – Page 2 of 15 IN THE NATIONAL COMPANY LAW TRIBUNAL, MUMBAI COURT-IV CA(CAA)/136/MB/2026 (i) The Transferor Company-1 is engaged in the business of manufacturer, exports, and trading in Specialty chemicals and other chemical products. (ii) The Transferor Company-2 is engaged in the business of manufacturer, trading, researchers, developers, creators of Specialty chemicals and other chemical products. (iii) The Transferee Company is engaged in the business of manufacture, trading and export of bulk Aroma and Specialty chemicals. 6. Rationale of the Scheme: The Applicant Companies stated that the rationale for the proposed scheme of amalgamation is as follows: 6.1 As the Transferor Companies 1 and 2 are engaged in a similar line of business to the Transferee Company, the amalgamation will enhance and strengthen the Transferee Company's business by improving its operational capabilities and market competitiveness. It aims to enrich the combined product offerings and expand the customer base both locally and globally. Consolidation as a single entity shall provide several benefits, such as opt [Showing first 8,000 characters — download PDF for full document]